ArticleOPEN ACCESS

mTOR inhibition in T-cell lymphoma: A path(way) forward

Blood
DOI: 10.1182/blood-2015-05-644724
3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this issue of Blood, Witzig et al report on the promising in vitro and in vivo activity of everolimus in T-cell lymphoma (TCL) and pave the way for future combination studies.1

Cite

CITATION STYLE

APA

Moskowitz, A. J., & Horwitz, S. M. (2015, July 16). mTOR inhibition in T-cell lymphoma: A path(way) forward. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-05-644724

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free